Blog
FDA 483 Observations: What They Are, Why They Happen, and How to Avoid Them
TLDR A 483 observation is a written finding issued by an FDA investigator when they spot conditions that may violate
Chemical Management Software: What Regulated Industries Need to Know
TLDR Chemical management software helps regulated industries track chemical inventories, manage safety data sheets (SDS), enforce procurement approvals, and stay
The True Total Cost of Ownership for eQMS Software: What Vendors Don’t Tell You
TLDR The sticker price of an eQMS platform is rarely the number that matters. For regulated life sciences and manufacturing
Document Control Software: What FDA-Regulated Companies Need to Know
TLDR Document control is one of the most consistently cited areas of FDA inspections and ISO audit findings. For pharmaceutical,
AI Agents for Quality Management in Medical Devices: What’s Actually Possible in 2026
TLDR AI agents are not replacing quality professionals in 2026. They are making quality systems faster, more predictive, and less
21 CFR Part 820 Risk Management: Requirements and How to Implement Them
TLDR On February 2, 2026, FDA's Quality Management System Regulation (QMSR) replaced the legacy Quality System Regulation (QSR) under 21